BioArctic receives patent in Japan for new antibodies targeting Parkinson’s disease

BioArctic AB announced that the Japanese Patent Office is granting a new drug substance patent for the antibody BAN0805, invented by BioArctic as a potential treatment of Parkinson’s disease.

Scroll to Top